Parkside Financial Bank & Trust’s Tourmaline Bio TRML Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-48	Closed	-$2.3K	–	2799
2025 Q3	$2.3K	Buy	48 +13	+37%	+$361	﹤0.01%	1971
2025 Q2	$561	Buy	+35	New	+$567	﹤0.01%	2476

Parkside Financial Bank & Trust's TRML Position: Q4 2025 in Review

Parkside Financial Bank & Trust sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 48 shares — an estimated $2.3K sold.

Parkside Financial Bank & Trust first reported a position in TRML in Q2 2025 and held it in 2 quarters. The position peaked at $2.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Parkside Financial Bank & Trust reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Parkside Financial Bank & Trust sold 48 Tourmaline Bio shares in Q4 2025, an estimated $2.3K.
Parkside Financial Bank & Trust first reported a position in Tourmaline Bio in Q2 2025 and held it in 2 quarters.
Parkside Financial Bank & Trust's Tourmaline Bio position peaked at $2.3K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2025, filed 13 Feb 2026.